DP Technology – the developer of a set of AI instruments utilized by researchers for work spanning drug design to battery growth – has raised greater than 800 million yuan (US$114 million) in Series C financing to develop analysis and growth (R&D) and rent expertise.
The Beijing-based AI-for-Science (AI4S) start-up mentioned on Wednesday that the round drew backing from a mixture of state-linked and enterprise buyers, together with Fortune Venture Capital, Beijing Jingguorui Equity Investment Fund, Beijing Artificial Intelligence Industry Investment Fund, Beijing Pharmaceutical and Health Industry Investment Fund, Lenovo Capital and Incubator Group and Oriza Hua.
The funding could be used primarily to recruit expertise and develop R&D, the corporate mentioned.
Founded in 2018 by two Peking University alumni, DP Technology focuses on growing AI4S instruments for elementary analysis, life sciences and supplies science. The sector makes use of synthetic intelligence and superior computing to speed up scientific discovery, from molecular simulation to laboratory automation.
DP Technology’s product line-up spans a number of levels of the analysis course of.
Its choices embrace Particle Universe, an AI mannequin system for scientific simulation; Bohrium, a cloud-based analysis platform and asset hub; and Uni-Lab, a laboratory working system.
The firm has additionally developed Hermite, a computer-aided drug design platform; RiDYMO, an R&D platform concentrating on beforehand “undruggable” organic targets; Piloteye, a battery design platform; Lebesgue Intelligent Computing, a computing site visitors controller; and SciMaster, a general-purpose scientific AI agent that integrates with its different merchandise.